THIRD ROCK VENTURES IV, L.P. enters MAZE THERAPEUTICS, INC. with 311.17K shares plus derivative instruments
Holding both equity and derivatives at entry signals strong long-term conviction in the company.
Direct Derivatives
Filed: 1/30/2025ACC: 0000950170-25-011306
10% Owner
Since Jan 2025
311.17K
Baseline shares
100% direct
311.17K
Direct ownership
1 position
64.73M
Derivative underlying
3 instruments
1
Security positions
All direct
Non-Derivative Holdings1
Common Stock
DirectShares owned311.17K
Total
311.17K direct311.17K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Common Stock | 311.17K | Direct |
| Total | 311.17K | 311.17K direct |
Derivative Holdings3
Series D-1 Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
9.73M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series A Preferred Stock
DirectUnderlying security
Common Stock
Underlying shares
45.83M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Series A Preferred Stock
IndirectUnderlying security
Common Stock
Underlying shares
9.17M
Shares owned
N/A
Exercise price
Expiration
—
Exercise window
—
Total
Underlying
64.73M
Owned
0.00
| Security | Underlying | Exercise Price | Exercise Window | Expiration | Underlying Shares | Shares Owned |
|---|---|---|---|---|---|---|
| Series D-1 Preferred Stock Direct | Common Stock | — | — | 9.73M | N/A | |
| Series A Preferred Stock Direct | Common Stock | — | — | 45.83M | N/A | |
| Series A Preferred Stock Indirect | Common Stock | — | — | 9.17M | N/A | |
| Total | 64.73M | 0.00 | ||||